ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA PATIENTS
AbstractBackground Antipsychotic medications have been reduced severity and duration of acute psychotic episode and the number of recurrent psychotic episodes among persons with schizophrenia by long-term use of this medication. However, poor adherence to antipsychotic medication in schizophrenia has been associated with increased rate of rehospitalisation and relapse. The nonadherence to antipsychotic medication is often underestimated. Good adherence to antipsychotic medication is one of the corner stones of long remissions. Conclusions On the basis of different studies it could be concluded that around one half of the schizophrenia patients have poor adherence to antipsychotic medication. To increase adherence to antipsychotic medication good therapeutic alliance should be established with positive emotions, bilateral communication and patient involvement in decision making. The adherence to the antipsychotic medication could be improved with the agreement about psychopharmacotherapy. Antipsychotic therapy should be understandable, tolerable and acceptable for the patient
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.